WallStSmart

Cintas Corporation (CTAS)vsLichen China Limited Class A Ordinary Shares (LICN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cintas Corporation generates 44876% more annual revenue ($11.03B vs $24.52M). CTAS leads profitability with a 17.6% profit margin vs -89.6%. CTAS earns a higher WallStSmart Score of 58/100 (C).

CTAS

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 9.0Value: 2.7Quality: 7.5
Piotroski: 6/9Altman Z: 4.29

LICN

Avoid

26

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 2/9Altman Z: 9.00
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTASSignificantly Overvalued (-38.5%)

Margin of Safety

-38.5%

Fair Value

$144.61

Current Price

$179.85

$35.24 premium

UndervaluedFair: $144.61Overvalued

Intrinsic value data unavailable for LICN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTAS4 strengths · Avg: 9.3/10
Return on EquityProfitability
40.5%10/10

Every $100 of equity generates 40 in profit

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

Market CapQuality
$69.91B9/10

Large-cap with strong market position

Operating MarginProfitability
23.2%8/10

Strong operational efficiency at 23.2%

LICN3 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0010/10

Safe zone — low bankruptcy risk

Areas to Watch

CTAS3 concerns · Avg: 3.3/10
P/E RatioValuation
36.9x4/10

Premium valuation, high expectations priced in

Price/BookValuation
15.0x4/10

Trading at 15.0x book value

PEG RatioValuation
2.762/10

Expensive relative to growth rate

LICN4 concerns · Avg: 2.5/10
Market CapQuality
$29.75M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-39.8%2/10

ROE of -39.8% — below average capital efficiency

Revenue GrowthGrowth
-56.1%2/10

Revenue declined 56.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CTAS

The strongest argument for CTAS centers on Return on Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 17.6% and operating margin at 23.2%.

Bull Case : LICN

The strongest argument for LICN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : CTAS

The primary concerns for CTAS are P/E Ratio, Price/Book, PEG Ratio.

Bear Case : LICN

The primary concerns for LICN are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

CTAS profiles as a mature stock while LICN is a turnaround play — different risk/reward profiles.

CTAS carries more volatility with a beta of 0.96 — expect wider price swings.

CTAS is growing revenue faster at 8.9% — sustainability is the question.

CTAS generates stronger free cash flow (531M), providing more financial flexibility.

Bottom Line

CTAS scores higher overall (58/100 vs 26/100), backed by strong 17.6% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cintas Corporation

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Cintas Corporation is an American corporation headquartered in Cincinnati, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses.

Lichen China Limited Class A Ordinary Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company is headquartered in Jinjiang, China.

Want to dig deeper into these stocks?